Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns

European Journal of Cancer

Volumn 40, Issue 10, 2004, Pages 1530-1538

  Verhoef, C ^a   Visser, O ^b   De Man, R A ^a   De Wilt, J H W ^a   Ijzermans, J N M ^a   Janssen Heijnen, M L G ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum Amsterdam   (Netherlands)

^c Eindhoven Cancer Registry   (Netherlands)

Author keywords

Hepatocellular carcinoma; Incidence; Mortality; Survival; Treatment; Trends

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER SURVIVAL; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MORTALITY; NETHERLANDS; PARTIAL HEPATECTOMY; PRIORITY JOURNAL;

ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NETHERLANDS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 2942514608     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.03.013     Document Type: Article

References (44)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int. J. Cancer. 94:2001;153-156
2. Ramsey W.H., Wu G.Y. Hepatocellular carcinoma: update on diagnosis and treatment. Dig. Dis. 13:1995;81-91
3. Bosch F.X., Ribes J. Epidemiology of liver cancer in Europe. Can. J. Gastroenterol. 14(7):2000;621-630
4. Taylor-Robinson S.D., Foster G.R., Arora S., Hargreaves S., Thomas H.C. Increase in primary liver cancer in the UK, 1979-94. Lancet. 350:1997;1142-1143
5. Deuffic S., Poynard T., Buffat L., Valleron A.J. Trends in primary liver cancer. Lancet. 351:1998;214-215
6. El-Serag H.B., Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340(10):1999;745-750
7. Stuart K.E., Anand A.J., Jenkins R.L. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome and survival. Cancer. 77:1996;2217-2222
8. Fong Y., Sun R.L., Jarnagin W., Blumgart L.H. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann. Surg. 229:1999;790-800
9. Zhou X.D., Tang Z.Y. Management of hepatocellular carcinoma: long-term outcome in 2639 cases. Gan To Kagaku Ryoho. 24(Suppl 1):1997;9-16
10. Cance W.G., Stewart A.K., Menck H.R. The national cancer database report on treatment patterns for hepatocellular carcinomas. Cancer. 88:2000;912-920
11. Sanden van der G.A.C., Coebergh J.W.W., Schouten L.J., Visser O., van Leeuwen F.E. Cancer incidence in the Netherlands in 1989 and 1990: first results of the nation-wide Netherlands Cancer Registry. Eur. J. Cancer. 31A:1995;1822-1829
12. Schouten L.J., Hoppener P., van den Brandt P.A., Knottnerus J.A., Jager J.J. Completeness of cancer registration in Limburg, the Netherlands. Int. J. Epidemiol. 22:1993;369-376
13. Berkel J. General practitioners and completeness of cancer registry. J. Epidem. Community Health. 44:1990;121-124
14. IARC/IACR. Multiple primaries. IARC Internal Report No. 94/003. Lyon, France: International Agency for Research on Cancer; 1994
15. Kleinbaum D.G., Kupper L.L., Muller K.E. Applied regression analysis and other multivariable methods. 1988;PWS-Kent Publishing Company, Boston
16. Ferlay J, Bray F, Sankila R, et al. European Network of Cancer Registries. EUROCIM user manual, 3rd ed., Lambda-Plus Software
17. Hermanek P., Sobin L.H. TNM classification of malignant tumors. 1992;Springer, Berlin. p. 104-112
18. Eurocare Working Group. Eurocare-III: survival of cancer patients diagnosed 1990-1994 results and commentary. Ann Oncol 2003 14(Suppl. 5), V61-V118
19. Visser O., Siesling S., van Dijck J.A.A.M. Incidence of cancer in the Netherlands 1999/2000. 2003;Vereniging van Integrale Kankercentra, Utrecht
20. Irvine H.D.V., Goldberg D., Hole D.J., McMenamm J. Trends in primary liver cancer. Lancet. 351:1998;215-216
21. McGlynn K.A., Tsao L., Hsing A.W., Devesa S.S., Fraumeni J.F. Jr. International trends and patterns of primary liver cancer. Int. J. Cancer. 94:2001;290-296
22. Sharp G.B., Cologne J.B., Fukuhara T., Itakura H., Yamamoto M., Tokuoka S. Temporal changes in liver cancer incidence rates in Japan: accounting for death certificate inaccuracies and improving diagnostic techniques. Int. J. Cancer. 93:2001;751-758
23. La Vecchia C., Lucchini F., Franceschi S., Negri E., Levi F. Trends in mortality from primary liver cancer in Europe. Eur. J. Cancer. 36:2000;909-915
24. Howe H.L., Wingo P.A., Thun M.J., et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl. Cancer Inst. 93:2001;824-842
25. Parkin DM, Whelan S, Ferlay J, et al. eds. Cancer incidence in five continents, 143rd ed., vol. VII. Lyon, France, IARC Scientific Publications, 1997
26. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 33:2001;1353-1357
27. Taylor-Robinson S.D., Toledano M.B., Arora S., et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut. 48:2001;816-820
28. Benhamiche A.M., Faivre C., Minello A., et al. Time trends and age-period-cohort effect on the incidence of primary liver cancer in a well-defined French population: 1976-1995. J. Hepatol. 29:1998;802-806
29. El-Serag H., Davilla J.A., Petersen N.J., McGlynn K.A. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann. Intern. Med. 139:2003;817-823
30. Poon R.T., Fan S.T., Tsang F.H.F., Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann. Surg. 235:2002;466-486
31. Gondolesi G., Munoz L., Matsumoto C., et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J. Gastrointest. Surg. 6:2002;102-107
32. Lise M., Bacchetti S., Da Pian P., Nitti D., Pilati P.L., Pigato P. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer. 82:1998;1028-1036
33. Zhou X.D., Tang Z.Y., Yang B.H., et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer. 91:2001;1479-1486
34. Nzeako U.C., Goodman Z.D., Ishak K.G. Hepatocellular carcinoma in cirrhotic and non cirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am. J. Clin. Path. 105:1996;65-75
35. Nakshima T., Okuda K., Kojiro M., et al. Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases autopsied in ten years. Cancer. 51:1983;863-877
36. Liver Cancer Study Group of Japan: clinicopathologic features and results of surgical treatment. Ann Surg 1990, 211, 277-287
37. Bismuth H., Chiche L., Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J. Surg. 19:1995;35-41
38. Fong Y., Sun R.L., Jarnagin W., Blumgart L.H. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann. Surg. 229:1999;790-800
39. Poon R.T., Fan S.T., Lo C.M., et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann. Surg. 236:2002;602-611
40. Wu C.C., Chen J.T., Ho W.L., et al. Liver resection for hepatocellular carcinoma in octogenarians. Surgery. 125:1999;332-338
41. Nagasue N., Chang Y.C., Takemoto Y., Taniura H., Kohno H., Nakamura T. Liver resection in the aged (seventy years or older) with hepatocellular carcinoma. Surgery. 113:1993;148-154
42. Llovet J.M., Bruix J., Fuster J., et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 27:1998;1572-1577
43. Ng I.O., Ng M.M., Lai E.C., Fan S.T. Better survival in female patients with hepatocellular carcinoma. Possible causes from a pathologic approach. Cancer. 75:1995;18-22
44. Faivre J, Forman D, Esteve J, Obradovic M, Sant M and the EUROCARE working group. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. Eur J Cancer 1998, 34, 2184-2190